-
公开(公告)号：US09943571B2
公开(公告)日：2018-04-17
申请号：US14102383
申请日：2013-12-10
申请人： MannKind Corporation
发明人： Peter Richardson , Robert A. Baughman , Elizabeth Potocka , Anders Hasager Boss , Richard Petrucci
CPC分类号： A61K38/28 , A61K9/0021 , A61K9/0075 , A61K47/545
摘要： Disclosed herein are improved methods of treating hyperglycemia with a combination of an ultrarapid acting insulin and insulin glargine comprising prandial administration of the ultrarapid insulin, and administration of a first dose of insulin glargine within 6 hours of waking for a day.
-
公开(公告)号：US20210244800A1
公开(公告)日：2021-08-12
申请号：US17240802
申请日：2021-04-26
申请人： MannKind Corporation
IPC分类号： A61K38/28 , A61K31/155 , A61K9/00
摘要： Disclosed herein are improved methods of treating hyperglycemia with a combination of an ultrarapid acting insulin and insulin glargine comprising prandial administration of the ultrarapid insulin, and administration of a first dose of insulin glargine within 6 hours of waking for a day.
-
公开(公告)号：US10857207B2
公开(公告)日：2020-12-08
申请号：US15910876
申请日：2018-03-02
申请人： MannKind Corporation
发明人： Peter Richardson , Robert A. Baughman , Elizabeth Potocka , Anders Hasager Boss , Richard Petrucci
摘要： Disclosed herein are improved methods of treating hyperglycemia with a combination of an ultrarapid acting insulin and insulin glargine comprising prandial administration of the ultrarapid insulin, and administration of a first dose of insulin glargine within 6 hours of waking for a day.
-
公开(公告)号：US11559569B2
公开(公告)日：2023-01-24
申请号：US16994404
申请日：2020-08-14
申请人： MannKind Corporation
摘要： Disclosed herein are improved methods of treating hyperglycemia with a combination of an ultrarapid acting insulin and insulin glargine comprising prandial administration of the ultrarapid insulin, and administration of a first dose of insulin glargine within 6 hours of waking for a day.
-
公开(公告)号：US10772935B2
公开(公告)日：2020-09-15
申请号：US16023996
申请日：2018-06-29
申请人： MannKind Corporation
摘要： Disclosed herein are improved methods of treating hyperglycemia with a combination of an ultrarapid acting insulin and insulin glargine comprising prandial administration of the ultrarapid insulin, and administration of a first dose of insulin glargine within 6 hours of waking for a day.
-
公开(公告)号：US20190307853A1
公开(公告)日：2019-10-10
申请号：US16385915
申请日：2019-04-16
申请人： MannKind Corporation
IPC分类号： A61K38/28 , A61K9/00 , A61K31/155
摘要： Disclosed herein are improved methods of treating hyperglycemia with a combination of an ultrarapid acting insulin and insulin glargine comprising prandial administration of the ultrarapid insulin, and administration of a first dose of insulin glargine within 6 hours of waking for a day.
-
公开(公告)号：US20170189492A1
公开(公告)日：2017-07-06
申请号：US15300239
申请日：2015-03-27
申请人： MannKind Corporation
CPC分类号： A61K38/28 , A61K9/0019 , A61K9/007 , A61K9/0075 , A61K31/155 , A61K2300/00
摘要： Disclosed herein are improved methods of treating hyperglycemia with a combination of an ultrarapid acting insulin and insulin glargine comprising prandial administration of the ultrarapid insulin, and administration of a first dose of insulin glargine within 6 hours of waking for a day.
-
公开(公告)号：US11013788B2
公开(公告)日：2021-05-25
申请号：US16385915
申请日：2019-04-16
申请人： MannKind Corporation
IPC分类号： A61K38/28 , A61K31/155 , A61K9/00
摘要： Disclosed herein are improved methods of treating hyperglycemia with a combination of an ultrarapid acting insulin and insulin glargine comprising prandial administration of the ultrarapid insulin, and administration of a first dose of insulin glargine within 6 hours of waking for a day.
-
公开(公告)号：US20180303909A1
公开(公告)日：2018-10-25
申请号：US16023996
申请日：2018-06-29
申请人： MannKind Corporation
摘要： Disclosed herein are improved methods of treating hyperglycemia with a combination of an ultrarapid acting insulin and insulin glargine comprising prandial administration of the ultrarapid insulin, and administration of a first dose of insulin glargine within 6 hours of waking for a day.
-
公开(公告)号：US10046031B2
公开(公告)日：2018-08-14
申请号：US15421743
申请日：2017-02-01
申请人： MannKind Corporation
摘要： Disclosed herein are improved methods of treating hyperglycemia with a combination of an ultrarapid acting insulin and insulin glargine comprising prandial administration of the ultrarapid insulin, and administration of a first dose of insulin glargine within 6 hours of waking for a day.
-
-
-
-
-
-
-
-
-
搜索结果
15 条记录 (耗时 0.01 秒)
